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Abstract. 
 
In T lymphocytes, the Src-family protein ty-
 
rosine kinase p56
 
lck
 
 (Lck) is mostly associated with the 
cytoplasmic face of the plasma membrane. To deter-
mine how this distribution is achieved, we analyzed the 
location of Lck in lymphoid and in transfected nonlym-
phoid cells by immunofluorescence. We found that in T 
cells Lck was targeted correctly, independently of the 
cell surface proteins CD4 and CD8 with which it inter-
acts. Similarly, in transfected NIH-3T3 fibroblasts, Lck 
was localized at the plasma membrane, indicating that 
T cell–specific proteins are not required for targeting. 
Some variation in subcellular distribution was observed 
when Lck was expressed in HeLa and MDCK cells. In 
these cells, Lck associated with both the plasma mem-
brane and the Golgi apparatus, while subsequent ex-
pression of CD4 resulted in the loss of Golgi-associated 
staining. Together, these data indicate that Lck con-
tains intrinsic signals for targeting to the plasma mem-
brane. Furthermore, delivery to this site may be 
achieved via association with exocytic transport vesi-
cles.
A mutant Lck molecule in which the palmitoylation 
site at cysteine 5 was changed to lysine (LC2) localized 
to the plasma membrane and the Golgi region in NIH-
3T3 cells. However, the localization of a mutant in 
which the palmitoylation site at cysteine 3 was changed 
to serine (LC1) was indistinguishable from wild-type 
Lck. Chimeras composed of only the unique domain of 
Lck linked to either c-Src or the green fluorescent pro-
tein similarly localized to the plasma membrane of 
NIH-3T3 cells. Thus, the targeting of Lck appears to be 
determined primarily by its unique domain and may be 
influenced by the use of different palmitoylation sites.
 
A
 
large number of cytosolic proteins associate with
membranes through long chain fatty acids covalently
attached to their amino or carboxyl termini. Ex-
amples include members of the Src-family, the alpha sub-
units of heterotrimeric G proteins, small GTP-binding pro-
teins, and retroviral matrix proteins. In a number of cases
these proteins have been found to associate with a specific
membrane compartment, e.g., c-Src associates with endo-
somal membranes (Kaplan et al., 1992), G
 
a
 
i-3 with the
Golgi complex (Ercolani et al., 1990), and the Gag protein
of Moloney murine leukemia virus with the plasma mem-
brane (Wills and Craven, 1991). However, little is known
about the mechanisms that underlie the targeting of acy-
lated proteins to their sites of function in the cell. To gain
more insight into this, we have analyzed the cellular distri-
bution of the myristoylated and palmitoylated Src-family
member Lck.
The Src-family of nonreceptor protein tyrosine kinases
currently consists of nine proteins (Src, Fyn, Lyn, Yes, Fgr,
Hck, Blk, Lck, and Yrk [for review see Rudd et al., 1993])
that play important roles in cell growth regulation and dif-
ferentiation. These proteins have overlapping but distinct
activities and tissue distributions. At the cellular level, Src-
family members have discrete subcellular localizations
that may in part determine the specific function of these
proteins. V-Src has been found in focal adhesions (Rohr-
schneider, 1980), c-Src on endosomes (Kaplan et al., 1992),
Fyn in the microtubule organizing center (Ley et al., 1994),
Hck on secretory granules (Mohn et al., 1995), and Lck at
the plasma membrane (Ley et al., 1994). Each Src-family
protein contains a nonhomologous domain of 
 
z
 
70 amino
acids at the NH
 
2
 
 terminus (the unique domain), followed
by a single Src homology 3 (SH3) domain, an SH2 domain,
and the tyrosine kinase or SH1 domain (see Rudd et al.,
1993) (Fig. 1). In addition, a short tyrosine-containing
(Y505 in Lck) motif at the COOH terminus regulates the
enzymatic activity of the protein (Cooper and Howell,
1993), and a conserved region (SH4 domain) at the ex-
treme NH
 
2
 
 terminus contains the signal(s) for acylation
(Fig. 1) (Resh, 1993). All family members are myristoy-
lated and, with the exception of Src and Blk, contain one
or two sites for palmitoylation (Koegl et al., 1994; Resh,
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1994). Thus far palmitoylation has been demonstrated for
Lck, Fyn, Hck, Yes, and Fgr (Paige et al., 1993; Alland et
al., 1994; Koegl et al., 1994; Shenoy-Scaria et al., 1994).
Lck is expressed in thymocytes and mature T lympho-
cytes and is crucial for the development (Molina et al.,
1992; Levin et al., 1993) and function (Straus and Weiss,
1992) of these cells. The localization of Lck at the cytosolic
side of the plasma membrane is consistent with its role in
facilitating signaling through the T cell antigen receptor
(TcR)
 
1
 
. It is well established that Lck interacts with CD4
and CD8 (Rudd et al., 1988; Veillette et al., 1988), the TcR
coreceptors on helper and cytotoxic T cells, respectively,
and that these interactions are important for T cell activa-
tion (Zamoyska et al., 1989; Glaichenhaus et al., 1991).
Lck also plays a role in regulating the endocytic properties
of CD4, thereby controlling the cellular distribution of this
coreceptor (Pelchen-Matthews et al., 1992). The interac-
tion of Lck with CD4 or CD8 is dependent on the pres-
ence of cysteine motifs in the cytoplasmic tails of the core-
ceptor molecules and in the unique domain of Lck (Shaw
et al., 1990; Turner et al., 1990).
Here, we have sought to determine factors that are im-
portant for the plasma membrane distribution of Lck. The
Lck domains confer a potential for numerous protein–pro-
tein and protein–lipid interactions, any of which might
contribute to the subcellular localization of this protein.
Palmitoylation and myristoylation at the SH4 domain play
a key role in the association of Lck with membranes. The
unique domain interacts with CD4 and CD8 (Rudd et al.,
1988; Veillette et al., 1988), the SH2 domain with phos-
pho-tyrosine–containing sequences (Pawson, 1995) and
phosphatidylinositol (Rameh et al., 1995), the SH3 domain
with proline-rich sequences (Pawson, 1995), and the ki-
nase domain with its tyrosine-containing substrates. Fur-
thermore, the regulatory COOH-terminal tyrosine is a
substrate for c-Src kinase (Csk) (Nada et al., 1991), the
CD45 phosphatases (Ostergaard et al., 1989) and, when
phosphorylated, interacts with the SH2 domain (Sieh et
al., 1993).
In addition to CD4 and CD8, Lck has been reported to
interact with a variety of other cell surface proteins, both
transmembrane and GPI-linked proteins, as well as with
plasma membrane–associated caveolae (Shenoy-Scaria et
al., 1994). Furthermore, an association of Lck with ele-
ments of the cytoskeleton has been suggested (Louie et al.,
1988; Kinch et al., 1994). The role of these interactions in
establishing and maintaining the subcellular distribution
of Lck is also unclear.
We analyzed the distribution of Lck by immunofluores-
cence and found that neither CD4, CD8, nor other T cell–
specific proteins are required for the plasma membrane
localization of Lck in T cells and transfected NIH-3T3 fi-
broblasts. The use of chimeras demonstrated that the unique
domain of Lck plays an important role in establishing the
plasma membrane localization in NIH-3T3 cells. Palmitoy-
lation of either Cys 3 or Cys 5 resulted in membrane asso-
ciation, confirming the result of others (Kwong et al., 1995;
Yurchak et al., 1995). However, an Lck mutant that con-
tains only the palmitoylation site at Cys 3 localized both to
the Golgi region and the plasma membrane, suggesting
that the position of the palmitic acid influences the subcel-
lular distribution of Lck. We observed cell type–specific
variation in the distribution of Lck: in HeLa cells, Lck was
partially found at the Golgi complex. This may suggest
that unidentified cellular components are involved in the
correct sorting of Lck, and furthermore, that Lck may be
transported to the plasma membrane via the exocytic pathway.
 
Materials and Methods
 
Reagents
 
Tissue culture reagents were from Gibco Ltd. (Paisley, UK), tissue culture
plastic was from Falcon Plastics, and chemicals were from Sigma Chemical
Co., (Poole, UK), unless indicated otherwise.
 
Cells
 
The human T cell lines, SupT1, BC7, A3.01, and A2.01, were cultured in
RPMI 1640 supplemented with 10% FCS. BC7 cells (provided by J.
Hoxie, University of Philadelphia, Philadelphia, PA) are CD4-negative
derivatives of SupT1 cells (Endres et al., 1996). A3.01 cells were selected
for HAT-sensitivity after mutagenesis of CEM T cells with 8-azaguanine
(Folks et al., 1985). A2.01 cells are CD4-negative derivatives of A3.01 cells.
A2.01 expressing CD4 without a cytoplasmic tail (A.201-CD4stop399)
and A3.01 were kindly provided by D. Littman (Skirball Institute, New
York).
NIH-3T3 fibroblasts and transfectants of these cells were grown in
 
1. 
 
Abbreviations used in this paper
 
: GFP, green fluorescent protein; Lck,
Src-family protein tyrosine kinase p56
 
lck
 
; TcR, T cell antigen receptor;
UD, unique domain.
Figure 1. Domain organization of the Src-family proteins and of
the Lck constructs used in this study. Lck is shown schematically
as a representative of Src-family proteins. Indicated are the
unique domain (UD), the Src Homology 3 (SH3), SH2, the ty-
rosine kinase (SH1) domains, and the short conserved COOH-
terminal region that contains the “regulatory” tyrosine (Y). The
amino acid sequence of the conserved NH2-terminal region, also
designated the SH4 domain, which contains the signals for acyla-
tion is shown for Lck. The attachment of myristic acid to glycine
(boxed) requires the removal of the NH2-terminal methionine
and the consensus sequence GXXXS/C. Palmitic acid is attached
to cysteines (encircled) and requires a myristoylated NH2-termi-
nal glycine and cysteine on position 3. Cysteine 5 in Lck is also a
palmitate acceptor site.
In this study we used Lck mutants with disruptions to the first
(LC1), the second (LC2), or both (LC1/2) palmitoylation sites
(Turner et al., 1990). Also depicted are the chimeras used in this
study: Lck/Src contains the unique domain of Lck and the re-
mainder of Src, Src/Lck contains the unique domain of Src and
the remainder of Lck (Turner et al., 1990). The chimera UD-GFP
is composed of the unique domain of Lck fused to the NH2 termi-
nus of green fluorescent protein. 
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DME containing 10% FCS, 100 U/ml penicillin, 0.1 mg/ml streptomycin
(Pen/Strep), and supplemented where appropriate with 1 mg/ml G418
and/or 0.2 mg/ml hygromycin (Boehringer Mannheim GmbH, Mannheim,
Germany). NIH-3T3 cells transfected with human CD4 and either murine
Lck, c-Src, Lck/Src, or Src/Lck have been described before (Pelchen-Mat-
thews et al., 1992). HeLa cells and HeLa transfectants were cultured in
DME containing 4% FCS, Pen/Strep (as above), and 1 mg/ml G418 where
appropriate. The HeLa cells expressing human CD4 used in this study
were made in our laboratory by Dr. C. Pitcher.
 
Transfections and DNA Constructs
 
Transfections of NIH-3T3 cells were carried out by electroporation in
HEBS buffer (20 mM Hepes, pH 7.05, 137 mM NaCl, 5 mM KCl, 0.7 mM
Na
 
2
 
HPO
 
4
 
, 6 mM 
 
d
 
-glucose) using a Gene Pulser at 350 V, 250 
 
m
 
F, infinite
 
V
 
 (Bio-Rad Laboratories, Richmond, CA). HeLa cells were transfected
using 450 V. Murine Lck (Marth et al., 1985) and the constructs LC1, LC2,
LC1/2, and Lck/Src (Turner et al., 1990) were all generously provided by
D. Littman. These constructs were subcloned behind the SV-40 promotor
of the pBabe/Hygro vector (Morgenstern and Land, 1990) and 10 
 
m
 
g
DNA was used per transfection. Resistant colonies were selected on 0.2
mg/ml hygromycin. A cDNA encoding human CD4 was cloned into pSG5
(Stratagene Ltd., Cambridge, UK). A cDNA encoding CD4 with a stop-
codon at position 399 (CD4
 
D
 
cyt) was prepared by site-directed mutagene-
sis using the Kunkel method.
The GFP cDNA (Prasher et al., 1992), containing a Ser to Thr mutation
at position 65 (Heim et al., 1995), was kindly provided by G. Gorrie (Med-
ical Research Council Laboratory for Molecular Cell Biology, London). A
murine Lck unique domain (UD)–green fluorescent protein (GFP) chi-
mera was made by three-step PCR using Taq polymerase. The first PCR
(PCR1) was performed using the Reverse Cycle primer (U.S. Biochemical
Corp., Cleveland, OH) and the oligonucleotide (5
 
9
 
)TCCTTTACTCAT-
CAGCGGGGATGC(3)
 
9 
 
(designated 413) with murine Lck cDNA cloned
into Bluescript KS. One half of the latter primer overlaps with the last 12
nucleotides of the unique domain of Lck and the other half with the first
12 nucleotides of GFP. The second PCR (PCR2) was performed with
GFP cDNA in pGW1, using oligonucleotide (5
 
9
 
)ATAAACAAGTTG-
GGCCAT(3
 
9
 
) (designated N2643) that anneals to the vector sequence
and as 5
 
9
 
 primer (5
 
9
 
)GCATCCCCGCTGATGAGTAAAGGA(3
 
9
 
) (des-
ignated 412), which is complementary to 413. In the third PCR, the com-
bined reaction products of PCR1 and PCR2 were used as templates for
the Reverse Cycle primer (5
 
9
 
) and N2643 (3
 
9
 
). The resulting product was
digested with EcoRI and cloned into pGW1 and sequenced using T7 se-
quenase (U.S. Biochemical Corp.).
 
Antibodies
 
The anti-CD4 mouse mAb Q4120 was provided by Q. Sattentau through
the Medical Research Council AIDS Directed Reagents Programme
(South Mimms, Potters Bar, UK). This antibody recognizes an epitope
that is identical to, or overlaps with, the Leu3a epitope. Two rabbit poly-
clonal antisera against Lck were used, both raised against a synthetic pep-
tide comprising residues 478–509. One (Lck I) was kindly provided by S.
Ley (National Institute for Medical Research, Mill Hill, UK), (Ley et al.,
1994) and used for immunofluorescence and electron microscopy. The
other (Lck II) was raised in our laboratory (Pelchen-Matthews et al.,
1992), affinity purified using the Lck-peptide immobilized on Reactigel
(Pierce and Warriner, Chester, UK), and used for immunoblotting. Both
antisera against Lck do not recognize other members of the Src-family.
This was assessed by immunofluorescence and immunoblotting of T cells
that do not express normal Lck (JCam.1 [Straus et al., 1992]) and untrans-
fected NIH-3T3 cells. The mAb 327 against v-Src was purchased from On-
cogene Science, Inc. (Manhassett, NY). The rat mAb 23C identifies 
 
b9
 
-COP
of the coatomer complex, under the conditions used (Willison et al., 1989;
Harrison-Lavoie et al., 1993). Peroxidase-conjugated goat anti–rabbit and
goat anti–mouse antibodies, as well as anti–mouse rhodamine, anti–rat
rhodamine, and anti–rabbit FITC reagents, were from Pierce and Warriner.
 
Immunofluorescence
 
T cells were immobilized on 13-mm-diam glass coverslips coated with 1
mg/ml poly-
 
l
 
-lysine in PBS. Adherent NIH-3T3 and HeLa cells were
plated on coverslips 2 d before analysis. Cells were fixed at room tempera-
ture with 3% paraformaldehyde for 15 min, quenched with 50 mM NH
 
4
 
Cl,
and permeablilized in 0.1% Triton TX-100 for 10 min at room tempera-
ture. All solutions were made in PBS. After preincubation for 10 min in
0.2% gelatin, cells were incubated for 1 h with primary antibodies diluted
in 0.2% gelatin: mAb Q4120 for CD4 (at 1.6 
 
m
 
g/ml), Lck I serum at 1:1,000
for Lck, and mAb 327 for Src at 0.1 
 
m
 
g/ml. Fluorescent second layer anti-
bodies were used at 1:2,000 dilution in 0.2% gelatin, and incubations were
again for 1 h. Coverslips were mounted in Moviol (Calbiochem-Nova-
chem, [UK] Ltd, Beeston, UK) and observed either with a fluorescence
microscope (Axioskop; Carl Zeiss, Inc., Thornwood, NY) or by confocal
microscopy using an Optiphot-2 microscope (Nikon Inc., Melville, NY)
equipped with an MRC 1024 laser scanning attachment (Bio-Rad Labora-
tories).
 
Microinjection
 
HeLa-Lck cells were seeded on 13-mm-diam coverslips 2 d before micro-
injection. Plasmid DNA containing cDNA for CD4 or CD4
 
D
 
cyt was di-
luted in sterile PBS to a final concentration of 100 
 
m
 
g/ml and injected into
the nuclei. During microinjection, the cells were maintained at 37
 
8
 
C, in
5% CO
 
2
 
. Typically, 50 cells were injected over a 15-min period and the
cells were returned to the incubator for 3 h before fixation and staining.
 
Membrane Preparation
 
Cells (7.5 
 
3
 
 10
 
6
 
) were washed once with ice-cold PBS, once with ice-cold
TEA buffer (10 mM triethanolamine, 10 mM acetic acid, 250 mM sucrose,
1 mM EDTA, pH 7.45), and subsequently resuspended in 0.5 ml TEA
buffer containing 1 mM PMSF. Cells were broken with a ball-bearing ho-
mogenizer (diameter: 0.1564 inch; ball: 0.1553 inch; H & Y Enterprise,
Redwood City, CA) until 75% of nuclei were free (
 
z
 
80 passes for T cells).
Unbroken cells and nuclei were removed by centrifugation for 5 min at
2,000 rpm at 4
 
8
 
C. Postnuclear supernatants were subsequently centrifuged
at 100,000 
 
g
 
 for 40 min at 4
 
8
 
C in an ultracentrifuge (Optima™ TLX; Beck-
man Instruments, Fullerton, CA). Membrane pellets were dissolved in
NP-40 lysis buffer. Proteins were precipitated by the addition of 4 vol
 
2
 
70
 
8
 
C acetone for 30 min, recovered by centrifugation at 13,000 
 
g
 
 for 15
min at 4
 
8
 
C, and resuspended in SDS-PAGE sample buffer. Samples from
membrane and supernatant preparations, representing equivalent numbers
of cells, were separated on 10% nonreducing SDS–polyacrylamide gels.
 
Immunoblotting
 
After electrophoresis, proteins were transferred to nitrocellulose mem-
branes (Schleicher and Schuell, Keene, NH). The membranes were incu-
bated in blocking buffer (10% skimmed milk powder [Marvel, Premier
Beverages, Adbaston, UK], 0.1% Tween-20 in PBS) overnight at 4
 
8
 
C. In-
cubation with primary antibody was for 1 h at room temperature. Lck was
detected using affinity-purified Lck II at 0.15 
 
m
 
g/ml in blocking buffer,
and CD4 using the mouse mAb Q4120 (1.6 
 
m
 
g/ml). HRP-conjugated goat
anti–rabbit and goat anti–mouse antibodies, diluted 1:2,000 in blocking
buffer, were used as secondary antibodies. Blots were developed using en-
hanced chemiluminescence (Amersham International plc, Little Chalfont,
UK) and visualized using autoradiography film (Fuji Photo Film Co. Ltd.,
Tokyo, Japan).
 
Electron Microscopy
 
For immunolabeling of cryosections, HeLa cells (untransfected or trans-
fected with Lck) were fixed in 4% paraformaldehyde in PBS containing
5% sucrose, for 1 h at room temperature. The cells were scraped from the
culture dish, pelleted, and processed for cryo-EM. Small blocks of gelatine
(10% wt/wt) embedded cells were infused with 2.3 M sucrose for 4 h at
4
 
8
 
C and then placed on specimen holders and frozen in liquid nitrogen.
Ultrathin cryosections were cut using an ultracut E/FC4E low tempera-
ture sectioning system (Reichert Jung, Vienna, Austria) and the sections
were collected with a mixture of methylcellulose and 2.3 M sucrose (Liou
and Slot, 1994). Immunolabeling was performed as described (Slot et al.,
1991) except that Lck I was used as primary antibody followed by goat
anti–rabbit IgG conjugated to 10-nm gold. Sections were viewed using a
transmission electron microscope (EM 400; Philips Electron Optic, Cam-
bridge, UK). 
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Results
 
Distribution of Lck in T Cells
 
In T lymphocytes, the TcR coreceptors CD4 and CD8 are
the principal binding determinants for Lck. This interac-
tion involves two cysteines in the unique domain of Lck
(at positions 20 and 23) and two cysteines in the cytoplas-
mic tail of CD4 (at positions 420 and 422 in human CD4)
or the CD8
 
a
 
 chain (at positions 194 and 196 in human
CD8a) (Shaw et al., 1990; Turner et al., 1990). As both
CD4 and CD8 are expressed at the cell surface, association
with these proteins could promote plasma membrane lo-
calization of Lck. When expressed in the absence of CD4
or CD8 in transfected nonlymphoid cells, Lck has been
found to associate with the plasma membrane to some ex-
tent (Kwong et al., 1995; Yurchak et al., 1995). Whether
the distribution of Lck is influenced by coexpression of
CD4 or CD8 has not been examined.
We compared the cellular distribution of Lck in a CD4-
positive human leukemia–derived T cell line, SupT1, and a
CD4-negative derivative of this cell line, BC7. In addition,
a second human CD4-positive (CD8-negative) CEM-
derived T cell line, A3.01, was compared with a derivative
of this line, A2.01-CD4stop399, which expresses a CD4
molecule lacking 34 of the 38 amino acids from its cyto-
plasmic domain. This truncation, which removes C420 and
C422, abolishes the ability of CD4 to interact with Lck
(Turner et al., 1990). The relative amount of Lck that is as-
sociated with CD4 varies between T cell lines (Rudd et al.,
1993). We determined this proportion to be at least 60 and
67% for SupT1 and A3.01 cells, respectively (not shown).
This was established by immunoblotting cell lysates for
Lck before and after depletion of CD4 by immunoprecipi-
tation. The relative amount of CD4 that is associated with
Lck in SupT1 cells was found to be at least 85% (not
shown). Thus, the majority of Lck molecules are normally
complexed with CD4 in these cells and vice versa.
For immunofluorescence, T cells were immobilized on
poly-
 
l
 
-lysine–coated coverslips, fixed, permeabilized, and
stained with antibodies against the COOH-terminal do-
main of Lck and the NH
 
2
 
-terminal ecto-domain of CD4. In
the CD4-positive cells SupT1 and A3.01, staining for Lck
was only found in permeabilized cells and overlapped ex-
tensively with that of CD4 (Fig. 2), indicating that the ma-
jority of Lck was associated with the cytosolic side of the
plasma membrane. The distribution of Lck in the absence
of interacting CD4 was determined in BC7 and A2.01-
CD4stop399 cells. In both cell types Lck staining was again
seen at the periphery of the cell. The clearest indication
that this represents plasma membrane staining can be seen
in A2.01-CD4stop399 cells, where Lck colocalizes with
tailless CD4 (Fig. 2). The plasma membrane staining of
Lck was evenly distributed in all cases and showed no ap-
parent clustering. In addition to plasma membrane stain-
ing, some perinuclear staining was observed for Lck, both
Figure 2. Distribution of Lck in T cells. Double indirect immunofluorescence staining of Lck and CD4 in the CD4-expressing T cell line
SupT1 and its CD4-negative derivative, BC7, as well as for the CD4-positive T cell line A3.01 and its derivative A2.01-CD4stop399, that
expresses CD4 without a cytoplasmic tail. Rabbit anti-Lck (Lck I) was detected with FITC-conjugated goat anti–rabbit antibodies, mu-
rine anti-CD4 (Q4120) with rhodamine-conjugated goat anti–mouse antibodies. Observation was by confocal microscopy of 3-mm-thick
optical sections. Bar, 12.5 mm. 
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in the presence and absence of interactive CD4 (Fig. 2; the
visibility of this staining depends on the plane of focus and
is therefore not apparent in all the cell profiles in these
fields). A similar perinuclear staining was previously de-
scribed for Lck in Jurkat T cells and ascribed to late endo-
somes (Ley et al., 1994). By subcellular fractionation we
found that this pool of Lck constitutes only a very minor
fraction (
 
,
 
5%) of the total amount of Lck (not shown).
CD4 staining was also found in the perinuclear area, par-
tially overlapping the Lck staining (see Fig. 2, SupT1
cells). This localization may reflect the presence of CD4 in
the exocytic pathway. We conclude that in T cells, Lck
preferentially localizes to the plasma membrane indepen-
dently of CD4 and, since CD8 is not expressed in A2.01-
CD4 stop399 cells, CD8.
 
Distribution of Lck in NIH-3T3 Cells
 
In addition to CD4 and CD8, a number of other plasma
membrane proteins, including CD2 (Bell et al., 1992; Carmo
et al., 1993), CD5 (Raab et al., 1994), the IL-2 receptor
(Hatakeyama et al., 1991), 4-1BB (Kim et al., 1993), and
various glycosyl-phosphatidylinositol (GPI)–(Thy-1, CD48,
CD55, and CD59) (Stefanova et al., 1991), have been
shown to interact with Lck, albeit with low stoichiometry.
To investigate whether any T cell–specific membrane pro-
tein is required for the cellular distribution of Lck, we sta-
bly transfected murine Lck cDNA into murine NIH-3T3
fibroblasts either with or without CD4. Neither CD4 nor
Lck are normally expressed in these cells.
The amount of Lck associated with CD4 in the dual
transfectants was found to be equivalent to that seen in T
cells (not shown). Immunofluorescence staining of NIH-
3T3 cells that express CD4 and Lck showed colocalization
of the two proteins at the plasma membrane (Fig. 3). As
with the T cells, the plasma membrane staining of Lck in
these flat fibroblastic cells was seen as a homogeneous, dif-
fuse staining that was visible to the extremities of the cell.
This staining was distinct from the cytosolic pattern seen
with Lck mutants that are unable to bind to membranes
(see Fig. 10). CD4 was also observed in a perinuclear pat-
tern resembling that of Golgi-associated antigens and might
represent CD4 in the exocytic pathway en route to the cell
surface. When Lck was expressed in the absence of CD4, a
homogeneous plasma membrane staining was again ob-
served. This staining was indistinguishable from that seen
in the presence of CD4 (Fig. 3). No clustering of Lck, in-
dicative of association with plasma membrane micro-
domains, was apparent.
To quantitate the association of Lck with membranes in
the presence and absence of CD4, CD4-positive and CD4-
negative T cell lines (Fig. 4 
 
A
 
) and NIH-3T3 cells (Fig. 4 
 
B
 
)
Figure 3. Distribution of Lck
in NIH-3T3 fibroblasts. Dou-
ble indirect immunofluores-
cence staining of Lck and CD4
in fibroblasts either stably
transfected with both CD4 and
murine Lck (left) or with mu-
rine Lck alone (right). Pri-
mary and secondary antibodies
were as described in the legend
to Fig. 1. Optical sections (3 mm)
were observed by confocal mi-
croscopy. Bar, 20 mm.
Figure 4. Membrane association of Lck in the presence and ab-
sence of CD4. Cells were broken by passage through a ball-bear-
ing homogenizer. After removal of unbroken cells and nuclei,
cellular membranes were recovered by centrifugation at 100,000 g
(P, pellet) and separated from the soluble fraction (S, superna-
tant). For each cell line, samples representing equivalent amounts
of cells were analyzed by SDS-PAGE and subsequent immuno-
blotting with the affinity-purified anti-Lck antibodies (Lck II).
(A) T cell lines expressing CD4 (SupT1 and A3.01), tailless CD4
(A2.01) or no CD4 (BC7). (B) NIH-3T3 cells transfected with
Lck alone, with both Lck and CD4, or with the palmitoylation
mutant LC1/2. 
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were homogenized and fractionated into a 100,000-
 
g
 
 mem-
brane pellet and supernatant. Western blotting revealed
that in all cell lines, Lck was exclusively present in the
membrane fraction, independently of the presence of
CD4. Association with CD4 therefore does not influence
recruitment of Lck to membranes. Nonpalmitoylated Lck
that does not associate with membranes (see Figs. 1 and
10) was found entirely in the supernatant fraction (Fig. 4 
 
B
 
).
We previously determined that the plasma membrane in
BHK cells constitutes 
 
z
 
18% of the total cellular mem-
brane area (excluding inner mitochondria membranes
[Griffiths et al., 1989]). As the surface areas of the mem-
brane compartments in NIH-3T3 cells are likely to be sim-
ilar to those in BHK cells, the exclusive presence of Lck at
the plasma membrane suggests that Lck is specifically
sorted to this compartment. This sorting appears to occur
independently of the expression of T cell–specific proteins.
 
Distribution of Lck in HeLa Cells
 
We stably expressed murine Lck in a second nonlymphoid
cell line, HeLa. In these cells, Lck showed a distribution
Figure 5. Distribution of Lck in HeLa cells. (A) HeLa cells stably expressing murine Lck were double-stained with antibodies against
Lck (Lck I) and b9-COP. Lck staining was detected with FITC-conjugated goat anti–rabbit antibodies, b9-COP staining with rhodamine-
conjugated goat anti–rat antibodies. (B) HeLa cells stably expressing human Lck were transfected with a cDNA encoding CD4. 2 d
later, the cells were double-stained for Lck and CD4 (as in Fig. 1). Note the difference in distribution of Lck between cells that express
CD4 (the four cells at the top) and cells that do not. Confocal images of a 3-mm optical section are shown. Bar, 20 mm. (C) Frozen thin
sections of untransfected HeLa cells (left) or HeLa cells transfected with human Lck (right) were labeled with an antibody against Lck
(Lck I) and as a second layer goat anti–rabbit IgG–conjugated gold (10 nm). Nu, nucleus; GC, Golgi complex; PM, plasma membrane.
Bar, 0.1 mm. 
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distinct from that seen in NIH-3T3 cells. The protein was
not only located at the plasma membrane, but was also
seen in the perinuclear region of the cells, in a pattern sim-
ilar to that described for Golgi-associated proteins (Fig. 5
 
A
 
). Costaining with an antibody against 
 
b9
 
-COP indicated
that this perinuclear staining of Lck overlapped with the
Golgi complex (Fig. 5 
 
A
 
). This was confirmed by immu-
nogold-electron microscopy. Frozen thin sections of HeLa-
Lck cells, stained with anti-Lck antibodies and protein A
gold showed label associated with elements of the Golgi
apparatus (Fig. 5 
 
C
 
). The Golgi association was not a con-
sequence of the heterologous expression of murine Lck in
human cells, as it was also observed for human Lck in
HeLa cells (Fig. 5 
 
B
 
). Nor was it due to overexpression of
Lck, since high level expression driven by the cytomega-
lovirus immediate early promotor (Fig. 5) and moderate
expression from the SV-40 early promotor showed similar
distributions (not shown). The Golgi association was not
unique to HeLa cells but was also observed when the pro-
tein was expressed in MDCK cells (not shown). It is possi-
ble that the cell type–specific variation in the cellular dis-
tribution of Lck reflects the involvement of cellular
components that are present in T cells and NIH-3T3 cells
but absent from HeLa and MDCK cells in establishing the
distribution of Lck.
We investigated whether coexpression with CD4 would
modulate the distribution of Lck. Hela-Lck cells were
transfected with cDNA for human CD4 and analyzed 2 d
later. We found that in the CD4-positive cells, Lck was ex-
clusively located at the plasma membrane, while in adja-
cent CD4-negative cells, Lck was still observed in the
Golgi region (Fig. 5 B). Similar results were observed for
cells expressing either murine Lck or human Lck. Thus,
association with CD4 either prevented deposition of Lck
on Golgi membranes or induced redistribution of Lck that
was already associated with the Golgi complex. To distin-
guish between these two possibilities, we expressed CD4
in HeLa-Lck cells by microinjection and analyzed the dis-
tribution of Lck soon after onset of CD4 synthesis. We ob-
served that as early as 3 h after injection of cDNA for
CD4, Golgi staining of Lck had disappeared and Lck was
located only at the plasma membrane (Fig. 6, left). In con-
trast, injection of cDNA encoding a tailless form of CD4
did not change the distribution of Lck (Fig. 6, right). Previ-
ous experiments have estimated the half-life of Lck to be
20–30 h (Hurley and Sefton, 1989). The disappearance of
the Golgi-associated Lck 3 h after microinjection of CD4
cDNA implies that newly synthesized CD4 can interact
with previously synthesized Lck located on the Golgi
membranes and facilitate the redistribution of this pool of
Lck. Thus in HeLa cells, the interaction between Lck and
CD4 can occur during transport of CD4 through the exo-
cytic pathway.
The Role of the Unique Domain of Lck
To determine the role of the unique domain of Lck in tar-
geting to the plasma membrane, we studied the cellular
distribution of chimeras between Lck and c-Src. These chi-
meras contain either the unique domain of murine Lck
and the remainder of c-Src (Lck/Src) or the unique do-
main of c-Src and the remainder of Lck (Src/Lck) (Fig. 1)
(Turner et al., 1990). The unique domains of Lck and c-Src
are not homologous apart from the signal for myristoyla-
tion at the extreme NH2 terminus (Resh, 1993 and 1994).
c-Src is modified by myristoylation only but contains an
additional polybasic region that enhances membrane asso-
ciation (Silverman and Resh, 1992). In contrast, Lck is
modified with both myristic and palmitic acid (Paige et al.,
1993).
Figure 6. Microinjection of
wild-type CD4 and tailless
CD4 into Hela-Lck cells.
HeLa cells stably expressing
human Lck were microin-
jected with cDNA for wild-
type CD4 (left) or tailless
CD4 (right). Cells were fixed
3 h after injection and
stained with antibodies
against Lck and CD4 (as in
Fig. 1). Note the difference in
distribution of Lck between
cells that were injected with
wild-type CD4 cDNA (left,
the three cells on the left)
and cells that were not in-
jected. Also note that injec-
tion with tailless CD4 cDNA
has no effect on the distribu-
tion of Lck (right, the cell in
the middle). Confocal images
of 3-mm optical sections are
shown. Bar, 15 mm.The Journal of Cell Biology, Volume 137, 1997 1036
In cells expressing c-Src we observed the protein at the
plasma membrane and in the perinuclear region (Fig. 7), a
distribution clearly different from that of Lck (Fig. 7). A
similar perinuclear distribution of c-Src was previously de-
scribed (Kaplan et al., 1992) and attributed to association
with late endosomes. The distribution of the Src/Lck chi-
mera was different from that of Lck despite containing
88% of the Lck protein sequence (Fig. 7). The staining
pattern for Src/Lck was more punctate than that of Lck
and concentrated on one side of the nucleus. This distribu-
tion also differs from that of Src, but the specific location
of this chimera remains to be identified. Nevertheless, it is
clear that the presence of SH2, SH3, and kinase domains
of Lck do not target this chimera exclusively to the plasma
membrane. In contrast, the Lck/Src chimera was mainly
found at the plasma membrane (Fig. 7) identical to Lck.
Thus, the unique domain of Lck seems sufficient to target
heterologous Src homology domains to the plasma mem-
brane in NIH-3T3 cells.
A similar result was obtained with a second chimera,
composed of the unique domain of Lck linked to the NH2
terminus of the GFP of Aequoria victoria. cDNA’s for this
chimera (designated UD-GFP) and GFP were transfected
separately into NIH-3T3 cells. The cells were fixed 2 d
later and observed by fluorescence microscopy. We found
that GFP localized to the cytoplasm and nucleus as de-
scribed previously (Fig. 8) (Ogawa et al., 1995). However,
UD-GFP was located at the plasma membrane, although
some protein was observed in the perinuclear region as
well (Fig. 8). In HeLa cells, UD-GFP again behaved simi-
larly to Lck. In the absence of CD4 the protein was found
at the plasma membrane and in the Golgi region (Fig. 9).
When transfected into CD4-expressing cells, UD-GFP was
located predominantly at the plasma membrane (Fig. 9).
However, the extent of redistribution in the presence of
CD4 was slightly less for UD-GFP than for Lck, as some
internal staining of UD-GFP remained in CD4-expressing
cells. Association of UD-GFP with CD4 could be demon-
Figure 7. Cellular distribution of chimeras
between Lck and Src. NIH-3T3 fibroblasts
were stably transfected either with Lck, c-Src,
Lck/Src, or Src/Lck as indicated. Src/Lck con-
tains the unique domain of c-Src and the re-
mainder of Lck, while Lck/Src contains the
unique domain of Lck and the remainder of
c-Src (see Fig. 1). Lck- and Src/Lck-express-
ing cells were stained with Lck I, and Src- and
Lck/Src-expressing cells were stained with the
anti-Src mAb 327. Cells were observed by flu-
orescence microscope. Bar, 20 mm.
Figure 8. Cellular distribution of GFP and UD-
GFP in NIH-3T3 cells. NIH-3T3 cells were trans-
fected either with GFP or UD-GFP, a chimera
composed of the unique domain of Lck linked to
GFP. Cells were fixed 2 d later and observed by
fluorescent confocal microscopy. Note the
plasma membrane distribution of UD-GFP as
opposed to the cytosolic distribution of GFP.
Confocal images of 3-mm optical sections are
shown. Bar, 15 mm.Bijlmakers et al. Subcellular Distribution of p56lck 1037
strated by coimmunoprecipitation with anti-CD4 antibod-
ies (not shown).
We conclude that despite the potential of the other do-
mains for extensive protein–protein interaction, the cellu-
lar distribution of Lck is determined primarily by its NH2-
terminal unique domain.
The Role of Palmitoylation
A short motif (SH4) at the NH2 terminus of Src-family ki-
nases contains signals for myristoylation and palmitoyla-
tion (Fig. 1). Myristic acid is attached to an NH2-terminal
glycine after removal of the methionine at position 1 (Fig.
10). In agreement with previous reports (Turner et al.,
1990; Kwong and Lublin 1995), we found that the absence
of both palmitoylation attachment sites in the Lck mutant
LC1/2 (Fig. 1) localized the protein to the cytosol in stably
transfected NIH-3T3 cells (Fig. 10 A), indicating that
myristoylation alone is not sufficient for membrane associ-
ation. Membrane association was also not detected by cell
fractionation (Fig. 4 B). We further found that LC1/2 also
localized to the cytosol when expressed in the presence of
CD4 (Fig. 10 B). Thus, the interaction of Lck with CD4 re-
quires initial membrane association of Lck.
Palmitoylation occurs on cysteines in the general motif
Met-Gly-Cys, where Gly 2 is myristoylated (Resh, 1994;
Milligan et al., 1995). In addition to Cys 3, Cys 5 in Lck
and Cys 6 in Fyn (Alland et al., 1994) are also palmitate
acceptor sites. For Lck, conflicting results have been re-
ported on the relative contribution of the two cysteines to
palmitoylation (Rodgers et al., 1994; Shenoy-Scaria et al.,
1994). The constructs LC1 and LC2, with either one or the
other palmitoylation site deleted (Fig. 1), both localized to
the plasma membrane (Fig. 10 A) in stably transfected
NIH-3T3 cells as was shown before by others (Yurchak et
al., 1995). However, we observed a striking difference in
distribution between LC1 and LC2: while the localization
of LC1 was indistinguishable from that of wild-type Lck,
LC2 was found at the plasma membrane and in the perinu-
clear region. The perinuclear staining of LC2 overlapped
with that of b9-COP (not shown), suggesting that this mu-
tant was associated with the Golgi complex in NIH-3T3
cells. A difference in localization between palmitoylation
mutants was also observed by Yurchak et al. (1995). How-
ever, they found that in stably transfected rat 208F fibro-
blasts, a mutant without Cys 5 (5LC2) localized to a
higher extent at the plasma membrane than wild-type Lck
or a mutant that lacks Cys 3 (5LC1). Lck and the Cys 3
mutant localized partially to the perinuclear region in their
experiments (Yurchak et al., 1995), but this staining does
not resemble the Golgi staining described here for LC2.
We do not know the cause for this discrepancy other than
that cell type–specific differences might influence localiza-
tion of Lck. Nevertheless, both sets of data show that the
position of the palmitic acid can influence the association
of Lck with specific membrane compartments.
Discussion
The tyrosine kinase Lck primarily associates with the cyto-
solic side of the plasma membrane in T cells. Here, we
have studied the subcellular distribution of wild-type and
Figure 9. Cellular distribution of UD-GFP in HeLa cells. UD-GFP
was transfected into HeLa cells (left) or into HeLa cells that ex-
press CD4 (right). Cells were fixed 2 d later and 3-mm optical sec-
tions were observed by confocal microscopy. Bar, 10 mm.
Figure 10. Cellular distribution of Lck palmitoylation mutants in
NIH-3T3 cells. (A) NIH-3T3 cells were stably transfected with ei-
ther wild-type Lck, LC1, LC2, or LC1/2 (see Fig. 1). Cells were
stained by indirect immunofluorescence with an antibody against
Lck (Lck I). (B) CD4-expressing NIH-3T3 cells were transfected
with LC1/2 and stained for Lck with Lck I. Cells were observed
by fluorescence microscopy. Bar, 25 mm.The Journal of Cell Biology, Volume 137, 1997 1038
mutant Lck in lymphoid and nonlymphoid cells to identify
determinants that influence the localization of this protein.
In particular, we have studied the contribution of CD4, the
unique domain of Lck and palmitoylation (see Table I for
summary).
The association of Lck with CD4 and CD8, coreceptors
of the TcR in helper and cytotoxic T cells, respectively, is
well established. In the cells used in this study, at least 60–
70% of Lck is associated with CD4. Cysteine motifs in Lck
and in CD4 (or CD8) are essential for the Lck-CD4 associ-
ation; however, the precise nature of the interaction and
where in the cell it is established is not understood. It has
been shown that Lck can associate with CD4 at the ER,
when CD4 is held in this compartment through association
with an ER-retained HIV-gp120 (Crise and Rose, 1992).
Furthermore, under conditions where Lck is overex-
pressed together with a construct containing the cytoplas-
mic tail of CD4, Lck was found to associate with an endo
H–sensitive form of this construct (Shaw et al., 1989).
These observations suggest that Lck and CD4 might inter-
act early in the exocytic pathway and subsequently move
together through the constitutive exocytic route to the
plasma membrane. Consequently, CD4 could have an ac-
tive role in establishing the cellular distribution of Lck.
However, we found that in T cells, neither CD4 nor CD8
are required for targeting Lck to the plasma membrane.
In addition to CD4 and CD8, other T cell–specific trans-
membrane proteins such as CD2 (Bell et al., 1992; Carmo
et al., 1993), CD5 (Raab et al., 1994), CD28 (August and
Dupont, 1994), the IL-2 receptor (Hatakeyama et al.,
1991), the IL-7 receptor (Page et al., 1995), and 4-1BB
(Kim et al., 1993) associate with Lck, albeit with a lower
stochiometry. The finding that Lck expressed in NIH-3T3
cells is also located primarily at the plasma membrane in-
dicated that T cell–specific proteins are not required for its
targeting.
Lck has also been shown to associate with various GPI-
linked proteins, including CD48, CD55, CD59, and Thy-1
(Stefanova et al., 1991). A role for these ubiquitously ex-
pressed proteins in Lck targeting cannot be excluded at
present. However, it should be noted that the association
with GPI-linked proteins is not specific for Lck, but also
occurs for other Src-family members that have different
subcellular distributions to Lck (Shenoy et al., 1993; Ste-
fanova et al., 1991; Ley et al., 1994). Furthermore, the in-
teraction of Src-family kinases with GPI-linked proteins is
not well understood and may reflect an ability of both
GPI-linked and myristoylated/palmitoylated proteins to
partition with specific membrane lipids under certain condi-
tions rather than a direct interaction. For one of the GPI–
linked proteins, CD59, we used anti-CD59 antibodies to
induce cap formation on the CD4-negative T cells BC7.
We failed to see cocapping of Lck, suggesting that the in-
teraction between these two proteins in living cells is mini-
mal (not shown). In contrast, cocapping of Lck with CD4
was observed (our unpublished data and Ley et al., 1994).
As far as the individual domains of Lck are concerned,
we found that the unique domain of Lck is important for
the subcellular distribution of the protein. A chimera of
Lck and c-Src, in which the unique domain of c-Src was
substituted for that of Lck, localized exclusively to the
plasma membrane. In contrast, c-Src itself localizes to the
plasma membrane and perinuclear region (Fig. 7). In addi-
tion, a chimera composed of the unique domain of Lck
and GFP (UD-GFP) also localized to the plasma mem-
brane, while GFP was found in the cytosol and nucleus
(Fig. 8). Thus, the SH2 and SH3 domains do not appear to
contain targeting information that is relevant under the
conditions of these experiments. This is in contrast to v-Src,
where the SH2 domain was found to be important for its
localization to focal adhesion sites (Okamura and Resh,
1994), and the signaling molecules phospholipase Cg and
GRB2 where the SH3 domain is crucial for localizing to
the actin cytoskeleton (Bar et al., 1993).
In HeLa and MDCK cells we found Lck located in the
Golgi region and at the plasma membrane. Microinjection
of a cDNA encoding Lck-interactive forms of CD4 led to
the loss of Golgi-associated Lck within 3 h, indicating that
newly synthesized CD4 can interact with this pool of Lck
and presumably facilitate its transport to the cell surface.
The notion that CD4 can provide a dominant signal for
Lck localization may also explain why ER-retained CD4
can cause Lck to be located on the ER (Crise and Rose,
1992). Currently, we do not know why wild-type Lck asso-
ciates with the Golgi in HeLa and MDCK cells but not in
T cells or NIH 3T3 cells. One hypothesis is that T cells and
NIH-3T3 cells express proteins that, in the absence of
CD4, allow efficient transport of Lck to the plasma mem-
Table I. The Subcellular Distribution of Lck and Lck Constructs in T Cells and Transfected Cells
T Cells NIH-3T3 HeLa
CD4 2 1 2121
Lck
Plasma membrane Plasma membrane Plasma membrane Plasma membrane
Plasma membrane
1 Golgi Plasma membrane
Lck/Src — — Plasma membrane Plasma membrane* — —
Src/Lck — — Perinuclear — —
Src — — Perinuclear — —
UD-GFP — — Plasma membrane — Plasma membrane 
1 Golgi
Plasma membrane
LC1 — — Plasma membrane  — — —
LC2 — — Plasma membrane
1 Golgi
———
LC1/2 — — Cytosol Cytosol — —
*Data not shown.Bijlmakers et al. Subcellular Distribution of p56lck 1039
brane and that these proteins are missing or limited in
HeLa and MDCK cells. However, it is also possible that in
HeLa and MDCK cells, Lck is retained in the Golgi com-
plex due to aberrant interactions with Golgi components.
Fusing NIH-3T3 cells with Lck-expressing HeLa cells might
allow us to discriminate between these possibilities. The
Golgi localization in HeLa cells might imply that newly
synthesised Lck is initially directed to an intracellular
membrane system and then transported to the plasma
membrane on vesicular intermediates either with or with-
out CD4/CD8.
In NIH-3T3 cells we also observed a Golgi distribution
for an Lck construct that has a mutation of the palmitoyla-
tion site at Cys 5. A mutant with a disruption of the first
palmitoylation site (Cys 3) showed a similar distribution to
that of wild-type Lck (Fig. 10 A). We assume that these
mutants were palmitoylated since they associated with
membranes and either Cys 3 or Cys 5 can be used for
palmitoylation (Kwong and Lublin, 1995; Rodgers et al.,
1994; Yurchak and Sefton, 1995). One explanation for the
difference in localization between the two Lck mutants
could be that the use of different palmitoylation sites pre-
disposes the protein to interact with the glycolipid do-
mains that have been proposed to mediate sorting in the
trans-Golgi network (Yoshimori et al., 1996). Some inter-
action of Lck with glycolipid domains has been reported
(Shenoy et al., 1993; Rodgers et al., 1994), but the signifi-
cance of this association remains to be determined. The
position of the palmitic acids on Lck may also influence
recognition by proteins that are involved in sorting Lck to
the plasma membrane. Whether parts of the unique do-
main other than the SH4 region influence the distribution
of Lck remains to be examined. The Golgi localization of
LC2 again implies that Lck could normally associate tran-
siently with elements of the exocytic pathway before being
deposited at the plasma membrane, while inefficient trans-
port results in retention of Lck on the Golgi complex.
Palmitoylation is crucial for stable association of Lck
with membranes. So far, all palmitoyl transferase activities
identified are membrane associated and, in some cases,
have been localized to parts of the exocytic pathway. A
palmitoyl transferase activity that acylates newly synthe-
sized transmembrane proteins has been localized to the in-
termediate compartment (Bonatti et al., 1989). Further-
more, the cytosolic peripheral membrane protein glutamic
acid decarboxylase (GAD65), requires targeting to the
Golgi region for palmitoylation (Solimena et al., 1994).
Recently, a palmitoyl transferase that is specific for myris-
toylated proteins and palmitoylates Fyn in vitro was par-
tially purified from bovine brain membranes (Berthiaume
and Resh, 1995). Together, these data imply that Lck is
initially targeted to a membrane system, possibly belong-
ing to the exocytic pathway, where palmitoylation occurs.
After membrane binding, Lck moves to the plasma mem-
brane. How Lck is sorted to the plasma membrane rather
than other cellular membrane systems remains to be de-
termined. However, the studies reported here provide a
basis on which these mechanisms can start to be unrav-
elled.
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